Ghana - Women's share of population ages 15+ living with HIV (%)

Women's share of population ages 15+ living with HIV (%) in Ghana was 67.90 as of 2020. Its highest value over the past 30 years was 67.90 in 2020, while its lowest value was 62.00 in 1990.

Definition: Prevalence of HIV is the percentage of people who are infected with HIV. Female rate is as a percentage of the total population ages 15+ who are living with HIV.

Source: UNAIDS estimates.

See also:

Year Value
1990 62.00
1991 62.60
1992 63.00
1993 63.40
1994 63.80
1995 64.10
1996 64.30
1997 64.60
1998 64.80
1999 65.00
2000 65.10
2001 65.30
2002 65.40
2003 65.50
2004 65.50
2005 65.50
2006 65.50
2007 65.40
2008 65.20
2009 65.00
2010 64.80
2011 64.60
2012 64.60
2013 64.70
2014 64.90
2015 65.20
2016 65.60
2017 66.10
2018 66.70
2019 67.30
2020 67.90

Limitations and Exceptions: The limited availability of data on health status is a major constraint in assessing the health situation in developing countries. Surveillance data are lacking for many major public health concerns. Estimates of prevalence and incidence are available for some diseases but are often unreliable and incomplete. National health authorities differ widely in capacity and willingness to collect or report information.

Statistical Concept and Methodology: HIV prevalence rates reflect the rate of HIV infection in each country's population. Low national prevalence rates can be misleading, however. They often disguise epidemics that are initially concentrated in certain localities or population groups and threaten to spill over into the wider population. In many developing countries most new infections occur in young adults, with young women especially vulnerable. Data on HIV are from the Joint United Nations Programme on HIV/AIDS (UNAIDS). Changes in procedures and assumptions for estimating the data and better coordination with countries have resulted in improved estimates of HIV and AIDS. The models, which are routinely updated, track the course of HIV epidemics and their impact, making full use of information in HIV prevalence trends from surveillance data as well as survey data. The models take into account reduced infectivity among people receiving antiretroviral therapy (which is having a larger impact on HIV prevalence and allowing HIV-positive people to live longer) and allow for changes in urbanization over time in generalized epidemics. The estimates include plausibility bounds, which reflect the certainty associated with each of the estimates.

Aggregation method: Weighted average

Periodicity: Annual

Classification

Topic: Health Indicators

Sub-Topic: Risk factors